Tutorial
RH CHAIN
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Tutorial
01
Overview
02
Follow the Money
03
Daily Brief
04
Live
05
Congress
06
Directory
07
Corporate Insiders
08
Government Money
09
Political Influence
10
Institutions
11
Washington Network
12
Follow the Power
13
Disclosure Clock
14
AI Investigator
15
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Tutorial
Lobbying registrant
AL
ARNOLD & PORTER KAYE SCHOLER LLP
Open in network
○
Watch profile
Disclosed transactions
0
Buys / sells
0 / 0
Max Insider Score
—
Connections
10
with evidence
Customize layout
Disclosed transactions
No records
No transactions recorded for this profile.
Verified connections
Lobbied for
evidence
Spyre Therapeutics, Inc.
LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
Lobbied for
evidence
NOVO NORDISK A S
LDA Q1Y 2026 first quarter · issues not listed · Aug 26, 2026
Lobbied for
evidence
TELEFLEX INC
LDA Q1 2026 first quarter · Medicare/Medicaid, Trade · Aug 26, 2026
Lobbied for
evidence
Invitation Homes Inc.
LDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
Lobbied for
evidence
HONEYWELL INTERNATIONAL INC
LDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
Lobbied for
evidence
Crocs, Inc.
LDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
Lobbied for
evidence
PERRIGO Co plc
LDA Q1Y 2026 first quarter · issues not listed · Aug 26, 2026
Lobbied for
evidence
REGENERON PHARMACEUTICALS, INC.
LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
Lobbied for
evidence
EXELIXIS, INC.
LDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Lobbied for
evidence
INTERNATIONAL BANCSHARES CORP
LDA Q1 2026 first quarter · Banking · Aug 26, 2026
Data sources
SEC FORM 4
3m ago
HOUSE PTR
3m ago
SEC 13F
3m ago
ROBINHOOD CHAIN
3m ago